The analysis of PCC showed significantly positive correlation of ATP6V1A with signature genes of each cross-talking pathway, which provided computational statistical evidence for the involvement of low ATP6V1A in AD pathogenesis via synaptic vesicle cycle, phagosome, and oxidative phosphorylation. This evidence concerns the gene ATP6V1A and Alzheimer disease.